2.2(top 8%)
Impact Factor
2.4(top 8%)
extended IF
54(top 7%)
H-Index
1.2K
authors
1.5K
papers
17.8K
citations
3.5K
citing journals
16.1K
citing authors

Most Cited Articles of Expert Review of Pharmacoeconomics and Outcomes Research

TitleYearCitations
Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold2008449
KIDSCREEN-52 quality-of-life measure for children and adolescents2005426
Cognitive behavior therapy via the Internet: a systematic review of applications, clinical efficacy and cost-effectiveness2012418
A point of minimal important difference (MID): a critique of terminology and methods2011345
The truly remarkable universality of half a standard deviation: confirmation through another look2004307
Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes2010256
Assessing and demonstrating data saturation in qualitative inquiry supporting patient-reported outcomes research2010216
Internet-delivered treatments with or without therapist input: does the therapist factor have implications for efficacy and cost?2007190
Interpreting patient-reported outcome results: US FDA guidance and emerging methods2011188
Economic burden of healthcare-associated infections: an American perspective2009185
Globalization and healthcare: understanding health and medical tourism2006168
The PedsQL as a pediatric patient-reported outcome: reliability and validity of the PedsQL Measurement Model in 25,000 children2005167
Valuing citizen and patient preferences in health: recent developments in three types of best-worst scaling2010164
Rating scales and Rasch measurement2011144
Discrete choice experiments to measure consumer preferences for health and healthcare2002134
The minimum clinically important difference for EQ-5D index: a critical review2014132
Patient recall and recall bias of health state and health status2004126
PRODISQ: a modular questionnaire on productivity and disease for economic evaluation studies2005121
Half standard deviation estimate of the minimally important difference in HRQOL scores?2004117
Cancer-related fatigue: prevalence, assessment and treatment strategies2011111
Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications2010111
Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance2009110
Premenstrual syndrome and premenstrual dysphoric disorder: quality of life and burden of illness2009109
Priority setting in health: origins, description and application of the Australian Assessing Cost-Effectiveness initiative2008105
Meta-analysis of rare and adverse event data200293